Skip to main content

Table 2 Effect of adjunctive devices on final health outcomes using different follow-up

From: Systematic review: comparative effectiveness of adjunctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention of native vessels

Outcome

WMF (M)

≤ 30d RR

(95% CI)

In-hospital RR (95% CI)

30d RR

(95% CI)

180d RR

(05% CI)

365d RR

(95% CI)

Catheter Aspiration

     

   Mortality

0.79

0.65 (0.39 to 1.10)

0.81 (0.23 to 2.86)

0.61 (0.35 to 1.07)

0.89 (0.31 to 2.51)

0.62 (0.39 to 0.98)

   Myocardial infarction

0.77

0.55 (0.24 to 1.25)

0.32 (0.03 to 3.06)

0.60 (0.25 to 1.45)

0.70 (0.24 to 1.99)

0.51 (0.26 to 1.00)

   Stroke

0.79

3.18 (0.73 to 13.88)

4.94 (0.52 to infinity)

2.77 (0.51 to 14.98)

---*

---†

Target

revascularization

0.70

0.85 (0.53 to 1.38)

1.35 (0.26 to 6.94)

0.82 (0.50 to 1.35)

0.62 (0.40 to 0.96)

0.87 (0.63 to 1.19)

   MACE

0.79

0.80 (0.57 to 1.12)

0.97 (0.36 to 2.58)

0.79 (0.56 to 1.13)

0.66 (0.47 to 0.94)

0.61 (0.26 to 1.41)

   HRQoL

---

---

---

---

---

---

Mechanical Thrombectomy

     

   Mortality

1

1.25 (0.47 to 3.32)

1.00 (0.24 to 4.16)‡

1.25 (0.47 to 3.32)

1.35 (0.53 to 3.44)

0.50 (0.21 to 1.17)

   Myocardial infarction

1

0.63 (0.21 to 1.96)

1.00 (0.11 to 9.41)‡

0.63 (0.21 to 1.96)

0.57 (0.17 to 1.92)

0.66 (0.13 to 3.29)

   Stroke

1

1.89 (0.55 to 6.48)

---*

1.89 (0.55 to 6.48)

2.05 (0.27 to 15.78)

1.99 (0.26 to 15.14)

Target

revascularization

1

1.62 (0.21 to 12.55)

---*

1.62 (0.21 to 12.55)

0.55 (0.33 to 0.92)

0.68 (0.41 to 1.13)

   MACE

1

1.28 (0.37 to 4.38)

---†

1.28 (0.37 to 4.38)

0.71 (0.41 to 1.20)

0.66 (0.44 to 0.97)

   HRQoL

---

---

---

---

---

---

Distal Filter Embolic Protection

     

   Mortality

1

1.02 (0.50 to 2.08)

---†

1.02 (0.50 to 2.08)

1.25 (0.38 to 4.16)‡

0.87 (0.43 to 1.78)‡

   Myocardial infarction

1

0.73 (0.12 to 4.44)

---†

0.73 (0.12 to 4.44)

0.09 (0 to 0.74)*

2.35 (0.61 to 8.90)‡

   Stroke

1

1.51 (0.30 to 7.52)‡

---†

1.51 (0.30 to 7.52)‡

---†

---†

Target

revascularization

1

3.02 (0.61 to 14.84)

---†

3.02 (0.70 to 13.01)‡

1.00 (0.35 to 2.82)‡

1.78 (1.09 to 2.93)‡

   MACE

1

1.29 (0.77 to 2.15)

---†

1.29 (0.77 to 2.15)

1.10 (0.68 to 1.78)

1.48 (1.03 to 2.15)‡

   HRQoL

---

---

---

---

---

---

Distal Balloon Embolic Protection

    

   Mortality

1

0.64 (0.30 to 1.39)

0.69 (0.24 to 2.03)‡

0.64 (0.30 to 1.39)

0.86 (0.48 to 1.57)

---†

   Myocardial infarction

1

0.85 (0.32 to 2.23)

0.32 (0.00 to 3.71)‡

0.85 (0.32 to 2.23)

0.67 (0.29 to 1.57)

---†

   Stroke

1

0.11 (0 to 0.94)‡

---†

0.11 (0 to 0.94)‡

0.48 (0.10 to 2.22)‡

---†

Target

revascularization

1

1.38 (0.55 to 3.50)

0.32 (0.00 to 3.71)‡

1.38 (0.55 to 3.50)

0.93 (0.61 to 1.42)

---†

   MACE

1

0.74 (0.44 to 1.23)

---*

0.74 (0.44 to 1.23)

0.87 (0.64 to 1.19)

---†

   HRQoL

---

---

---

---

---

---

Proximal Balloon Embolic Protection

    

   Mortality

1

1.01 (0.14 to 7.10)‡

---†

1.01 (0.18 to 5.69)‡

0.51 (0.11 to 2.33)‡

---†

   Myocardial infarction

1

0.68 (0.11 to 3.99)‡

---†

0.68 (0.14 to 3.34)‡

1.01 (0.24 to 4.33)‡

---†

   Stroke

1

0.34 (0.01 to 8.23)‡

---†

0.34 (0 to 3.87)‡

0.20 (0.00 to 1.93)‡

---†

Target

revascularization

1

0.51 (0.13 to 1.99)‡

---†

0.51 (0.14 to 1.81)‡

0.71 (0.29 to 1.75)‡

---†

   MACE

1

0.61 (0.23 to 1.63)‡

---†

0.61 (0.23 to 1.57)‡

0.74 (0.36 to 1.54)‡

---†

   HRQoL

---

---

---

---

---

---

Embolic Protection Devices

     

   Mortality

1

0.84 (0.50 to 1.39)

0.69 (0.24 to 2.03)‡

0.84 (0.50 to 1.39)

0.87 (0.52 to 1.46)

0.87 (0.43 to 1.78)‡

   Myocardial infarction

1

0.83 (0.41 to 1.69)

0.32 (0.00 to 3.71)‡

0.83 (0.41 to 1.69)

0.65 (0.31 to 1.33)

2.35 (0.61 to 8.90)‡

   Stroke

1

0.56 (0.11 to 2.84)

---†

0.56 (0.11 to 2.84)

0.39 (0.09 to 1.71)

---†

Target

revascularization

1

1.24 (0.62 to 2.48)

0.32 (0.00 to 3.71)‡

1.24 (0.62 to 2.48)

0.90 (0.63 to 1.30)

1.78 (1.09 to 2.93)‡

   MACE

1

0.92 (0.66 to 1.30)

---*

0.92 (0.66 to 1.30)

0.91 (0.71 to 1.16)

1.48 (1.03 to 2.15)‡

   HRQoL

---

---

---

---

---

---

  1. Abbreviations: d = day; CI = confidence interval; HRQoL = health-related quality of life; m = months; MACE = major adverse cardiovascular events; N = number; = relative risk; WMF = weighted mean follow-up
  2. * Risk could not be calculated because no events occurred in the trial evaluating this outcome
  3. † Risk could not be calculated because no trials evaluated this outcome
  4. ‡ Result is based on a single trial